En Ren

2.7k total citations · 1 hit paper
46 papers, 2.2k citations indexed

About

En Ren is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, En Ren has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biomedical Engineering, 22 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in En Ren's work include Nanoplatforms for cancer theranostics (24 papers), RNA Interference and Gene Delivery (11 papers) and Nanoparticle-Based Drug Delivery (7 papers). En Ren is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), RNA Interference and Gene Delivery (11 papers) and Nanoparticle-Based Drug Delivery (7 papers). En Ren collaborates with scholars based in China, United States and Singapore. En Ren's co-authors include Gang Liu, Xin Pang, Xiaohong Chen, Yang Zhang, Chengchao Chu, Peng Lv, Jing Zhu, Yi Cheng, Junqing Wang and Yunming Zhang and has published in prestigious journals such as Cell, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

En Ren

44 papers receiving 2.2k citations

Hit Papers

A nanovaccine for antigen self-presentation and immunosup... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
En Ren China 24 1.4k 754 552 458 292 46 2.2k
Tzu‐yin Lin United States 26 1.3k 0.9× 748 1.0× 643 1.2× 682 1.5× 211 0.7× 80 2.4k
Peng Lv China 16 966 0.7× 723 1.0× 425 0.8× 315 0.7× 276 0.9× 36 1.7k
Bingyang Chu China 31 1.8k 1.3× 867 1.1× 513 0.9× 1.4k 3.0× 173 0.6× 70 3.1k
Kim M. Tsoi Canada 11 971 0.7× 524 0.7× 691 1.3× 520 1.1× 179 0.6× 36 2.0k
Yeh‐Hsing Lao United States 27 1.1k 0.8× 1.7k 2.2× 429 0.8× 584 1.3× 309 1.1× 59 2.8k
Ann‐Marie Broome United States 24 699 0.5× 977 1.3× 304 0.6× 551 1.2× 354 1.2× 44 2.4k
Haitao Ran China 26 1.3k 0.9× 517 0.7× 426 0.8× 597 1.3× 197 0.7× 88 2.0k
Yujuan Gao China 24 956 0.7× 1.0k 1.4× 573 1.0× 1.0k 2.2× 95 0.3× 68 2.4k
Cheng‐Liang Peng Taiwan 24 1000 0.7× 630 0.8× 395 0.7× 806 1.8× 126 0.4× 61 2.1k
Ke Li China 30 1.8k 1.3× 803 1.1× 659 1.2× 817 1.8× 466 1.6× 89 3.0k

Countries citing papers authored by En Ren

Since Specialization
Citations

This map shows the geographic impact of En Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by En Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites En Ren more than expected).

Fields of papers citing papers by En Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by En Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by En Ren. The network helps show where En Ren may publish in the future.

Co-authorship network of co-authors of En Ren

This figure shows the co-authorship network connecting the top 25 collaborators of En Ren. A scholar is included among the top collaborators of En Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with En Ren. En Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yan‐Ming, Xiaoge Zhang, Han Xiao, et al.. (2025). Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy. Cell. 189(3). 872–886.e23.
2.
Zhang, Qian, et al.. (2024). Bio-Hybrid Magnetic Robots: From Bioengineering to Targeted Therapy. Bioengineering. 11(4). 311–311. 11 indexed citations
3.
Su, Kexin, Xinxin Yan, Lu Shi, et al.. (2024). Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo. Journal of Controlled Release. 376. 395–401. 19 indexed citations
4.
Liang, Tingxizi, Ping Wen, Fengqin Li, et al.. (2024). In situ formation of biomolecular condensates as intracellular drug reservoirs for augmenting chemotherapy. Nature Biomedical Engineering. 8(11). 1469–1482. 24 indexed citations
5.
Zhu, Chaojie, Chao Liu, Qing Wu, et al.. (2024). Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors. Signal Transduction and Targeted Therapy. 9(1). 307–307. 18 indexed citations
6.
Ren, En, Yanfang Wang, Tingxizi Liang, et al.. (2023). Local Drug Delivery Techniques for Triggering Immunogenic Cell Death. Small Methods. 7(9). e2300347–e2300347. 14 indexed citations
7.
Lin, Lan, Lai Jiang, En Ren, & Gang Liu. (2023). Bioorthogonal chemistry based on-demand drug delivery system in cancer therapy. Frontiers of Chemical Science and Engineering. 17(4). 483–489. 7 indexed citations
8.
Chen, Bing, Chengchao Chu, En Ren, et al.. (2022). Metal Ion-Based Supramolecular Self-Assembly for Cancer Theranostics. Frontiers in Chemistry. 10. 870769–870769. 6 indexed citations
9.
He, Pan, En Ren, Biao‐Qi Chen, et al.. (2022). A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma. Theranostics. 12(4). 1769–1782. 44 indexed citations
10.
Dai, Qixuan, Lin Wang, En Ren, et al.. (2022). Ruthenium‐Based Metal–Organic Nanoradiosensitizers Enhance Radiotherapy by Combining ROS Generation and CO Gas Release. Angewandte Chemie International Edition. 61(50). e202211674–e202211674. 48 indexed citations
11.
Gao, Xing, En Ren, & Gang Liu. (2022). Membrane fusion boosting drug transmembrane delivery. SHILAP Revista de lepidopterología. 3. 254–256. 8 indexed citations
12.
Zhang, Yang, Hongwei Cheng, Hu Chen, et al.. (2021). A pure nanoICG-based homogeneous lipiodol formulation: toward precise surgical navigation of primary liver cancer after long-term transcatheter arterial embolization. European Journal of Nuclear Medicine and Molecular Imaging. 49(8). 2605–2617. 39 indexed citations
13.
Lv, Peng, Xiaomei Chen, En Ren, et al.. (2021). Surface engineering of oncolytic adenovirus for a combination of immune checkpoint blockade and virotherapy. Biomaterials Science. 9(22). 7392–7401. 16 indexed citations
14.
Zhang, Yang, Xiaoyong Wang, Chengchao Chu, et al.. (2020). Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics. Nature Communications. 11(1). 5421–5421. 122 indexed citations
15.
He, Yi, En Ren, Zhenhui Lu, et al.. (2020). Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis. Nanomedicine Nanotechnology Biology and Medicine. 28. 102210–102210. 23 indexed citations
16.
Zheng, Huili, Yesi Shi, Qixuan Dai, et al.. (2020). Tumor microenvironment-triggered MoS2@GA-Fe nanoreactor: A self-rolling enhanced chemodynamic therapy and hydrogen sulfide treatment for hepatocellular carcinoma. Chemical Engineering Journal. 406. 126888–126888. 57 indexed citations
17.
Ren, En, et al.. (2019). Mineral iron based self-assembling: bridging the small molecular drugs and transformative application. Science Bulletin. 64(4). 216–218. 6 indexed citations
18.
Chen, Haimin, Zainen Qin, Jinmin Zhao, et al.. (2019). Cartilage-targeting and dual MMP-13/pH responsive theranostic nanoprobes for osteoarthritis imaging and precision therapy. Biomaterials. 225. 119520–119520. 132 indexed citations
19.
Chu, Chengchao, En Ren, Yunming Zhang, et al.. (2018). Zinc(II)‐Dipicolylamine Coordination Nanotheranostics: Toward Synergistic Nanomedicine by Combined Photo/Gene Therapy. Angewandte Chemie International Edition. 58(1). 269–272. 123 indexed citations
20.
Lin, Gan, Yang Zhang, Congqing Zhu, et al.. (2018). Photo-excitable hybrid nanocomposites for image-guided photo/TRAIL synergistic cancer therapy. Biomaterials. 176. 60–70. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026